Yajin Chen

3.9k total citations
43 papers, 959 citations indexed

About

Yajin Chen is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Yajin Chen has authored 43 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Hepatology and 13 papers in Oncology. Recurrent topics in Yajin Chen's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), RNA modifications and cancer (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Yajin Chen is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), RNA modifications and cancer (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers). Yajin Chen collaborates with scholars based in China, United States and Taiwan. Yajin Chen's co-authors include Changzhen Shang, Min Jun, Wenliang Tan, Lihong Lv, Guolin Li, Yun-Le Wan, Mei Yang, Wei Zhang, Haoming Lin and Yan Lin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yajin Chen

39 papers receiving 949 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yajin Chen China 15 550 340 235 195 165 43 959
Hengjun Gao China 18 399 0.7× 344 1.0× 253 1.1× 193 1.0× 137 0.8× 50 931
Guoan Xiang China 17 439 0.8× 210 0.6× 192 0.8× 121 0.6× 111 0.7× 50 853
Chaohui Zuo China 17 422 0.8× 273 0.8× 169 0.7× 128 0.7× 126 0.8× 45 823
Kunlin Xie China 19 827 1.5× 635 1.9× 293 1.2× 152 0.8× 134 0.8× 46 1.3k
Jiayin Yang China 17 311 0.6× 261 0.8× 287 1.2× 195 1.0× 148 0.9× 68 861
Xiaoqing Jiang China 18 663 1.2× 484 1.4× 239 1.0× 176 0.9× 94 0.6× 33 1.1k
Yongfu Xiong China 19 516 0.9× 312 0.9× 254 1.1× 80 0.4× 211 1.3× 56 1.0k
Yunlong Cui China 18 462 0.8× 346 1.0× 287 1.2× 297 1.5× 213 1.3× 52 1.1k
Chung-Ta Lee Taiwan 15 420 0.8× 307 0.9× 197 0.8× 80 0.4× 139 0.8× 37 866
Xiaoping Geng China 17 320 0.6× 181 0.5× 205 0.9× 159 0.8× 147 0.9× 81 886

Countries citing papers authored by Yajin Chen

Since Specialization
Citations

This map shows the geographic impact of Yajin Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yajin Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yajin Chen more than expected).

Fields of papers citing papers by Yajin Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yajin Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yajin Chen. The network helps show where Yajin Chen may publish in the future.

Co-authorship network of co-authors of Yajin Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Yajin Chen. A scholar is included among the top collaborators of Yajin Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yajin Chen. Yajin Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Xiang, Jingwei Zheng, Yajin Chen, et al.. (2024). Prognostic value and association of the age-adjusted Charlson Comorbidity Index with sarcopenia within patients with gastric cancer after radical resection. Journal of Gastrointestinal Surgery. 28(7). 1089–1094. 3 indexed citations
3.
Xu, Yunxiuxiu, Yajin Chen, Tao Chen, et al.. (2024). Apatinib and camrelizumab plus Intravenous FOLFOX or hepatic arterial infusion chemotherapy with FOLFOX for advanced HCC: A multicenter, prospective, randomized phase III trial.. Journal of Clinical Oncology. 42(16_suppl). TPS4193–TPS4193. 3 indexed citations
4.
Chen, Tao, Yajin Chen, Yunxiuxiu Xu, et al.. (2024). Updated results from venous infusion chemotherapy (VIC) plus apatinib and camrelizumab for hepatocellular carcinoma (HCC) in CNLC stage III: A prospective, single-arm, phase II trial.. Journal of Clinical Oncology. 42(16_suppl). 4112–4112. 3 indexed citations
5.
Chen, Yajin, Chengyou Du, Shunli Shen, et al.. (2024). Toripalimab Plus Bevacizumab as First-line Treatment for Advanced Hepatocellular Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Trial. Clinical Cancer Research. 30(14). 2937–2944. 7 indexed citations
6.
Yang, Lei, Hongkai Zhuang, Xinming Chen, et al.. (2024). Lenvatinib inhibits cholangiocarcinoma progression by targeting the FGF19/PI3K/AKT signaling pathway. APOPTOSIS. 30(1-2). 185–196. 1 indexed citations
7.
Zhuang, Hongkai, Qingbin Wang, Ziyu Zhang, et al.. (2024). CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing BIRC3 mRNA. Cell Death and Disease. 15(3). 191–191. 9 indexed citations
8.
Wang, Qingbin, Wenliang Tan, Ziyu Zhang, et al.. (2024). FAT10 induces immune suppression by upregulating PD-L1 expression in hepatocellular carcinoma. APOPTOSIS. 29(9-10). 1529–1545. 4 indexed citations
9.
Sun, Zhixian, Huilong Li, Xuan Luo, et al.. (2024). Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy. Journal for ImmunoTherapy of Cancer. 12(7). e008953–e008953. 23 indexed citations
10.
Xie, Zhiqin, Hongxia Li, Ziyu Zhang, et al.. (2023). Trends in prevalence and all-cause mortality of metabolic dysfunction-associated fatty liver disease among adults in the past three decades: Results from the NHANES study. European Journal of Internal Medicine. 110. 62–70. 11 indexed citations
11.
Wang, Qingbin, Hongkai Zhuang, Zhiqin Xie, et al.. (2023). Identification of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and Responsiveness to Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 1–16. 3 indexed citations
12.
Zhuang, Hongkai, Lei Yang, Zhiqin Xie, et al.. (2022). SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression. SHILAP Revista de lepidopterología. 9 indexed citations
13.
Xie, Zhiqin, Hongxia Li, Wenliang Tan, et al.. (2022). Association of Serum Vitamin C With NAFLD and MAFLD Among Adults in the United States. Frontiers in Nutrition. 8. 795391–795391. 28 indexed citations
14.
Zhuang, Hongkai, Bo Chen, Xinming Chen, et al.. (2022). Identification of LSM Family Members as Novel Unfavorable Biomarkers in Hepatocellular Carcinoma. Frontiers in Oncology. 12. 871771–871771. 16 indexed citations
15.
Tan, Wenliang, Kelin Zhang, Xinming Chen, et al.. (2022). GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma. Journal of Advanced Research. 44. 173–183. 39 indexed citations
16.
Zhuang, Hongkai, Shujie Wang, Bo Chen, et al.. (2021). Prognostic Stratification Based on HIF-1 Signaling for Evaluating Hypoxic Status and Immune Infiltration in Pancreatic Ductal Adenocarcinomas. Frontiers in Immunology. 12. 790661–790661. 15 indexed citations
17.
Chen, Jie, Xicheng Wang, Xining Wang, et al.. (2020). A FITM1-Related Methylation Signature Predicts the Prognosis of Patients With Non-Viral Hepatocellular Carcinoma. Frontiers in Genetics. 11. 99–99. 4 indexed citations
18.
Zhou, Rui, Dihan Lu, Wenda Li, et al.. (2019). Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis. HPB. 21(7). 784–792. 66 indexed citations
19.
Yin, Zi, Chao Liu, Yajin Chen, et al.. (2013). Timing of hepatectomy in resectable synchronous colorectal liver metastases (SCRLM): Simultaneous or delayed?. Hepatology. 57(6). 2346–2357. 84 indexed citations
20.
Lv, Lihong, Yun-Le Wan, Yan Lin, et al.. (2012). Anticancer Drugs Cause Release of Exosomes with Heat Shock Proteins from Human Hepatocellular Carcinoma Cells That Elicit Effective Natural Killer Cell Antitumor Responses in Vitro. Journal of Biological Chemistry. 287(19). 15874–15885. 381 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hengjun Gao Breakdown of academic impact, for papers by Guoan Xiang Breakdown of academic impact, for papers by Chaohui Zuo Breakdown of academic impact, for papers by Kunlin Xie Breakdown of academic impact, for papers by Jiayin Yang Breakdown of academic impact, for papers by Xiaoqing Jiang Breakdown of academic impact, for papers by Yongfu Xiong Breakdown of academic impact, for papers by Yunlong Cui Breakdown of academic impact, for papers by Chung-Ta Lee Breakdown of academic impact, for papers by Xiaoping Geng
Rankless by CCL
2026